These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 39206530)

  • 1. Microbiome in sickle cell disease: Pathophysiology and therapeutic insights.
    Gupta CL; Jaganathasamy N; Madkaikar M
    Br J Haematol; 2024 Oct; 205(4):1279-1287. PubMed ID: 39206530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The gut microbiome in sickle cell disease: Characterization and potential implications.
    Brim H; Taylor J; Abbas M; Vilmenay K; Daremipouran M; Varma S; Lee E; Pace B; Song-Naba WL; Gupta K; Nekhai S; O'Neil P; Ashktorab H
    PLoS One; 2021; 16(8):e0255956. PubMed ID: 34432825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intestinal pathophysiological and microbial changes in sickle cell disease: Potential targets for therapeutic intervention.
    Dutta D; Aujla A; Knoll BM; Lim SH
    Br J Haematol; 2020 Feb; 188(4):488-493. PubMed ID: 31693163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sickle cell vaso-occlusive crisis: it's a gut feeling.
    Lim SH; Fast L; Morris A
    J Transl Med; 2016 Dec; 14(1):334. PubMed ID: 27906010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dietary iron restriction protects against vaso-occlusion and organ damage in murine sickle cell disease.
    Li H; Kazmi JS; Lee S; Zhang D; Gao X; Maryanovich M; Torres L; Verma D; Kelly L; Ginzburg YZ; Frenette PS; Manwani D
    Blood; 2023 Jan; 141(2):194-199. PubMed ID: 36315910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sickle cell disease: a review for the internist.
    Pinto VM; Balocco M; Quintino S; Forni GL
    Intern Emerg Med; 2019 Oct; 14(7):1051-1064. PubMed ID: 31385153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microbial gut evaluation in an angolan paediatric population with sickle cell disease.
    Delgadinho M; Ginete C; Santos B; Mendes J; Miranda A; Vasconcelos J; Brito M
    J Cell Mol Med; 2022 Nov; 26(21):5360-5368. PubMed ID: 36168945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gut microbiota dysbiosis alters chronic pain behaviors in a humanized transgenic mouse model of sickle cell disease.
    Kashyap Y; Wang ZJ
    Pain; 2024 Feb; 165(2):423-439. PubMed ID: 37733476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sickle Cell Disease Update: New Treatments and Challenging Nutritional Interventions.
    Bell V; Varzakas T; Psaltopoulou T; Fernandes T
    Nutrients; 2024 Jan; 16(2):. PubMed ID: 38257151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microbiome's Universe: Impact on health, disease and cancer treatment.
    Réthi-Nagy Z; Juhász S
    J Biotechnol; 2024 Sep; 392():161-179. PubMed ID: 39009231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. From dysbiosis to defense: harnessing the gut microbiome in HIV/SIV therapy.
    Brenchley JM; Serrano-Villar S
    Microbiome; 2024 Jun; 12(1):113. PubMed ID: 38907315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological interventions for painful sickle cell vaso-occlusive crises in adults.
    Cooper TE; Hambleton IR; Ballas SK; Johnston BA; Wiffen PJ
    Cochrane Database Syst Rev; 2019 Nov; 2019(11):. PubMed ID: 31742673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unraveling mechanistic insights into the role of microbiome in neurogenic hypertension: A comprehensive review.
    Dai Y; Shen Z; Khachatryan LG; Vadiyan DE; Karampoor S; Mirzaei R
    Pathol Res Pract; 2023 Sep; 249():154740. PubMed ID: 37567034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Revisiting anemia in sickle cell disease and finding the balance with therapeutic approaches.
    Xu JZ; Thein SL
    Blood; 2022 May; 139(20):3030-3039. PubMed ID: 35587865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unraveling the Microbiome-Human Body Axis: A Comprehensive Examination of Therapeutic Strategies, Interactions and Implications.
    Olteanu G; Ciucă-Pană MA; Busnatu ȘS; Lupuliasa D; Neacșu SM; Mititelu M; Musuc AM; Ioniță-Mîndrican CB; Boroghină SC
    Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microbiomes in physiology: insights into 21st-century global medical challenges.
    Shehata E; Parker A; Suzuki T; Swann JR; Suez J; Kroon PA; Day-Walsh P
    Exp Physiol; 2022 Apr; 107(4):257-264. PubMed ID: 35081663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nitric oxide: A potential etiological agent for vaso-occlusive crises in sickle cell disease.
    Gupta P; Kumar R
    Nitric Oxide; 2024 Mar; 144():40-46. PubMed ID: 38316197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic Approach Targeting Gut Microbiome in Gastrointestinal Infectious Diseases.
    Han Z; Min Y; Pang K; Wu D
    Int J Mol Sci; 2023 Oct; 24(21):. PubMed ID: 37958637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sickle cell anemia in the pediatric intensive care unit: novel approaches for managing life-threatening complications.
    Jenkins TL
    AACN Clin Issues; 2002 May; 13(2):154-68. PubMed ID: 12011590
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.